Validated Method Based on Immunocapture and Liquid Chromatography Coupled to High-Resolution Mass Spectrometry to Eliminate Isatuximab Interference with M-Protein Measurement in Serum

De Novo Sequencing of Antibody Light Chain Proteoforms from Patients with Multiple Myeloma

(2021) Mathieu Dupré et al.   ANALYTICAL CHEMISTRY

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

(2021) Philippe Moreau et al.   LANCET

Tracking of low disease burden in multiple myeloma: Using mass spectrometry assays in peripheral blood

(2020) Jessica R. Chapman et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Mass Spectrometry for Identification, Monitoring, and Minimal Residual Disease Detection of M-Proteins

(2020) M Zajec et al.   CLINICAL CHEMISTRY

Integrating Serum Protein Electrophoresis with Mass Spectrometry, A New Workflow for M-Protein Detection and Quantification

(2020) Marina Zajec et al.   JOURNAL OF PROTEOME RESEARCH

High-Throughput Therapeutic Antibody Interference-Free High-Resolution Mass Spectrometry Assay for Monitoring M-Proteins in Multiple Myeloma

(2020) Rasa Santockyte et al.   ANALYTICAL CHEMISTRY

Evaluating Isatuximab Interference with Monoclonal Protein Detection By Immuno-Capture and Liquid Chromatography Coupled to High Resolution Mass Spectrometry in the Pivotal Phase 3 Multiple Myeloma Trial, Icaria-MM

(2019) Greg Finn et al.   BLOOD

M-Protein semi-quantification in MM serum patients based on Immuno-Capture and Liquid Chromatography coupled to High Resolution Mass Spectrometry

(2019) Stéphane Muccio et al.   Clinical Lymphoma Myeloma & Leukemia

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

(2019) Michel Attal et al.   LANCET

Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood

(2018) Kazunori Murata et al.   CLINICAL BIOCHEMISTRY

Development of a Targeted Mass-Spectrometry Serum Assay To Quantify M-Protein in the Presence of Therapeutic Monoclonal Antibodies

(2018) Marina Zajec et al.   JOURNAL OF PROTEOME RESEARCH

Mass spectrometry methods for detecting monoclonal immunoglobulins in multiple myeloma minimal residual disease

(2018) Katie L. Thoren   SEMINARS IN HEMATOLOGY

Toward best practices in data processing and analysis for intact biotherapeutics by MS in quantitative bioanalysis

(2017) John F Kellie et al.   Bioanalysis

Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry

(2016) M. C. Kohlhagen et al.   CLINICAL CHEMISTRY

Challenges of measuring monoclonal proteins in serum

(2016) David F. Keren et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

(2016) Shaji Kumar et al.   LANCET ONCOLOGY

Detecting monoclonal immunoglobulins in human serum using mass spectrometry

(2015) John R. Mills et al.   METHODS

Monitoring M-Proteins in Patients with Multiple Myeloma Using Heavy-Chain Variable Region Clonotypic Peptides and LC–MS/MS

(2014) David R. Barnidge et al.   JOURNAL OF PROTEOME RESEARCH